Sphere Fluidics, a UK-based healthcare company, has raised £1.65m ($2.5m) in its series A round from a consortium including University of Cambridge’s Cambridge Enterprise technology commercialization fund.

Other investors included investment firm 24Haymarket, non-profit Royal Society, and angel investors, including Hermann Hauser’s Providence Investment Company. 

Frank Craig, chief executive of Sphere Fluidics, said: “There was strong interest in the company and we were pleased to welcome 24Haymarket into an impressive syndicate of investors. I am excited about further applying our…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?